Spero Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-2.91 | $-33.34 |
| FY2022 | $-1.23 | $-29.34 |
| FY2023 | $0.43 | $-26.03 |
| FY2024 | $-1.27 | $-23.56 |
| FY2025 | $0.15 | $-16.51 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-2.91 | $-33.34 |
| FY2022 | $-1.23 | $-29.34 |
| FY2023 | $0.43 | $-26.03 |
| FY2024 | $-1.27 | $-23.56 |
| FY2025 | $0.15 | $-16.51 |